PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.07%
Positive revenue growth while 3088.T is negative. John Neff might see a notable competitive edge here.
12.51%
Gross profit growth above 1.5x 3088.T's 0.95%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
23.80%
EBIT growth below 50% of 3088.T's 54.20%. Michael Burry would suspect deeper competitive or cost structure issues.
26.60%
Positive operating income growth while 3088.T is negative. John Neff might view this as a competitive edge in operations.
30.23%
Net income growth under 50% of 3088.T's 70.25%. Michael Burry would suspect the firm is falling well behind a key competitor.
30.16%
EPS growth under 50% of 3088.T's 68.68%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
30.16%
Diluted EPS growth under 50% of 3088.T's 68.68%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.00%
Share reduction while 3088.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3653.82%
OCF growth under 50% of 3088.T's 44155.56%. Michael Burry might suspect questionable revenue recognition or rising costs.
509.88%
FCF growth 1.25-1.5x 3088.T's 400.10%. Bruce Berkowitz would see if capex decisions or cost controls create a cash flow advantage.
30.68%
10Y revenue/share CAGR above 1.5x 3088.T's 14.06%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
30.68%
5Y revenue/share CAGR above 1.5x 3088.T's 14.06%. David Dodd would look for consistent product or market expansions fueling outperformance.
30.68%
3Y revenue/share CAGR above 1.5x 3088.T's 14.06%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
34.12%
10Y OCF/share CAGR under 50% of 3088.T's 303.94%. Michael Burry would worry about a persistent underperformance in cash creation.
34.12%
Below 50% of 3088.T's 303.94%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
34.12%
3Y OCF/share CAGR under 50% of 3088.T's 303.94%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
47.18%
Net income/share CAGR at 50-75% of 3088.T's 68.41%. Martin Whitman might question if the firm’s product or cost base lags behind.
47.18%
5Y net income/share CAGR at 50-75% of 3088.T's 68.41%. Martin Whitman might see a shortfall in operational efficiency or brand power.
47.18%
3Y net income/share CAGR 50-75% of 3088.T's 68.41%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
48.51%
10Y equity/share CAGR above 1.5x 3088.T's 13.40%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
48.51%
5Y equity/share CAGR above 1.5x 3088.T's 13.40%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
48.51%
3Y equity/share CAGR above 1.5x 3088.T's 13.40%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
16.67%
10Y dividend/share CAGR above 1.5x 3088.T's 7.69%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
16.67%
5Y dividend/share CAGR above 1.5x 3088.T's 7.69%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
16.67%
3Y dividend/share CAGR above 1.5x 3088.T's 7.69%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
No Data
No Data available this quarter, please select a different quarter.
2.94%
We show growth while 3088.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
11.00%
Positive asset growth while 3088.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
6.15%
BV/share growth above 1.5x 3088.T's 3.26%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
21.53%
We have some new debt while 3088.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.